Zhao Wu

3.0k total citations · 1 hit paper
28 papers, 1.9k citations indexed

About

Zhao Wu is a scholar working on Epidemiology, Hepatology and Neurology. According to data from OpenAlex, Zhao Wu has authored 28 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Hepatology and 6 papers in Neurology. Recurrent topics in Zhao Wu's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis C virus research (8 papers). Zhao Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis C virus research (8 papers). Zhao Wu collaborates with scholars based in China, United States and Israel. Zhao Wu's co-authors include Hong Zhao, Chi Zhang, Gui-Qiang Wang, Jiawen Li, Xiao Ma, Gui‐Qiang Wang, Qichao Hu, Jiawen Li, Guiqiang Wang and Jing Jiang and has published in prestigious journals such as Blood, Medicine and Investigative Ophthalmology & Visual Science.

In The Last Decade

Zhao Wu

25 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

2020 1.3k citations Chi Zhang, Zhao Wu et al. International Journal of Antimicrobial Agents profile →

Peers

Zhao Wu

NEURO

ONCOL

EPIDE

Xiaoxin Wu China

Haizhou Wang China

Baoguang Hu China

Yan Xiong China

Jiong Yu China

Weina Guo China

Yan Qin China

Jiawen Li China

Chenhui Wang China

Yueping Liu China

Xiaoxin Wu China

Zhao Wu

1.3k ×1.3

678 ×1.0

NEURO

331 ×1.1

ONCOL

367 ×1.3

486 ×2.3

EPIDE

Citations per year, relative to Zhao Wu Zhao Wu (= 1×) peers Xiaoxin Wu

Countries citing papers authored by Zhao Wu

Since Specialization

Citations

This map shows the geographic impact of Zhao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao Wu more than expected).

Fields of papers citing papers by Zhao Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao Wu. The network helps show where Zhao Wu may publish in the future.

Co-authorship network of co-authors of Zhao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhao Wu. A scholar is included among the top collaborators of Zhao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao Wu. Zhao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Zhao, et al.. (2025). A Deep Q-Network-driven multi-objective evolutionary algorithm for distributed heterogeneous hybrid flow shop scheduling with worker fatigue. Engineering Applications of Artificial Intelligence. 162. 112292–112292.

Li, Zhigang, Chang‐Ming Huang, Fei Cheng, et al.. (2024). Association between dietary inflammatory index and fecal incontinence in American adults: a cross-sectional study from NHANES 2005–2010. Frontiers in Nutrition. 11. 1364835–1364835. 4 indexed citations

Wu, Zhao, et al.. (2024). Psychological burden of hearing-impaired children and their parents through the COVID-19 pandemic. Frontiers in Public Health. 12. 1403729–1403729. 1 indexed citations

Jiao, Fengjuan, Le‐Ting Zhou, & Zhao Wu. (2024). The microbiota-gut-brain axis: a potential target in the small-molecule compounds and gene therapeutic strategies for Parkinson’s disease. Neurological Sciences. 46(2). 561–578. 4 indexed citations

Wu, Zhao, et al.. (2023). Astragaloside IV reduces lung injury in lethal sepsis via promoting treg cells expansion and inhibiting inflammatory responses.. PubMed. 36(6). 1709–1718. 2 indexed citations

Li, Jun, Zhao Wu, Guiqiang Wang, & Hong Zhao. (2021). Hepatitis B core-related antigen reflects viral replication and protein production in chronic hepatitis B patients. Chinese Medical Journal. 134(10). 1160–1167. 3 indexed citations

Wu, Zhao, Xinyu Deng, Qichao Hu, et al.. (2021). Houttuynia cordata Thunb: An Ethnopharmacological Review. Frontiers in Pharmacology. 12. 714694–714694. 87 indexed citations

Zhang, Chi, Zhao Wu, Jiawen Li, Hong Zhao, & Gui-Qiang Wang. (2020). Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. International Journal of Antimicrobial Agents. 55(5). 105954–105954. 1261 indexed citations breakdown →

Wu, Zhao, Anlin Ma, Qing Xie, et al.. (2020). Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT. Clinics and Research in Hepatology and Gastroenterology. 45(2). 101463–101463. 10 indexed citations

10.

Zhang, Chi, Zhao Wu, Jiawen Li, et al.. (2020). Combination of quantitative hepatitis B core antibody (qHBcAb) and aspartate aminotransferase (AST) can accurately diagnose immune tolerance of chronic hepatitis B virus infection based on liver biopsy. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101563–101563. 11 indexed citations

11.

Li, Jun, Zhao Wu, Anlin Ma, et al.. (2019). Unsatisfying antiviral therapeutic effect in patients with mother-to-child transmissed chronic hepatitis B virus infection. Chinese Medical Journal. 132(22). 2647–2656. 2 indexed citations

12.

Wang, Jiasheng, Yongxian Hu, Shuye Yang, et al.. (2019). Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 25(6). 1092–1098. 82 indexed citations

13.

Wu, Zhao, et al.. (2018). Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal. Journal of Viral Hepatitis. 26(2). 287–296. 8 indexed citations

14.

Wu, Zhao, et al.. (2018). Evaluation and comparison of thirty noninvasive models for diagnosing liver fibrosis in chinese hepatitis B patients. Journal of Viral Hepatitis. 26(2). 297–307. 31 indexed citations

15.

Hu, Yongxian, Jiasheng Wang, Chengfei Pu, et al.. (2018). Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy. Cancer Research and Treatment. 50(4). 1462–1466. 10 indexed citations

16.

Hu, Yongxian, Jiasheng Wang, Guoqing Wei, et al.. (2018). A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia. Bone Marrow Transplantation. 54(8). 1208–1217. 35 indexed citations

17.

Wu, Zhao, et al.. (2018). Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78‐week prospective study. Journal of Gastroenterology and Hepatology. 34(4). 755–763. 17 indexed citations

18.

Wu, Zhao, Zhi Liu, Shuang Liu, et al.. (2016). Anti-CD19 chimeric antigen receptor T-cell therapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Medicine. 95(51). e5676–e5676. 19 indexed citations

19.

Wu, Zhao, Peng Xue, Jinke Li, Yi Zhang, & Lina Hu. (2013). Constitutive Activation of Nuclear Factor κB Contributes to Cystic Fibrosis Transmembrane Conductance Regulator Expression and Promotes Human Cervical Cancer Progression and Poor Prognosis. International Journal of Gynecological Cancer. 23(5). 906–915. 32 indexed citations

20.

Wu, Zhao, Shuai Wang, Christine M. Sorenson, & Nader Sheibani. (2003). Hypoxia-Mediated Loss of Astrocytes Promotes the Pathogenesis of Oxygen-Induced Ischemic Retinopathy. Investigative Ophthalmology & Visual Science. 44(13). 2095–2095. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact